Pfizer Shares Set Intraday Record, Pacing COVID-19 Vaccine Makers The stock's surge reflects the increasing likelihood that the COVID-19 vaccine will be a durable business. 2 MIN READ 08.10.2021
Novavax Says Its Vaccine Is 90% Effective With 100% Protection Against Moderate and Severe COVID-19 The nearly 30,000-patient trial showed the vaccine had 93% effectiveness against known variants. (Image source: Novavax) 3 MIN READ 06.15.2021
States Scramble To Catch Up on Vaccines After Winter Storm Wreaks Havoc The severe weather led to clinic closures, canceled appointments and shipment backlogs nationwide (Image source: CVS Health) 5 MIN READ 02.24.2021
Top Executives at Novavax Have Sold $46 Million Worth of Company Stock in Past Year The company's COVID-19 vaccine candidate is still undergoing clinical trials. 6 MIN READ 01.11.2021
Novavax Begins Phase 3 Trial of COVID-19 Vaccine Candidate in United States The company had delayed the trial twice due to issues in scaling up the manufacturing process. 1 MIN READ 12.29.2020
Serum Institute of India Sees AstraZeneca’s COVID-19 Vaccine As ‘Very Good’ Option It's a major vote of confidence from the world's largest vaccine producer. 2 MIN READ 11.30.2020
